GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹342 Cr | ₹151 Cr | ₹238 Cr | ₹177 Cr | ₹181 Cr |
What is the latest Capital Work in Progress ratio of GLAND PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹342 Cr |
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹238 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹181 Cr |
How is Capital Work in Progress of GLAND PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹342 Cr | 127.27 | |
| Mar2025 | ₹151 Cr | -36.71 | |
| Mar2024 | ₹238 Cr | 34.23 | |
| Mar2023 | ₹177 Cr | -1.95 | |
| Mar2022 | ₹181 Cr | - | |
Compare Capital Work in Progress of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹42,583.2 Cr | 6.2% | 4.8% | 24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 6.2% |
4.8% |
24.3% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses